Tuesday afternoon trading saw a decrease in health care stocks, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) falling 0.3%.
iShares Biotechnology ETF (IBB) experienced a 0.1% decline.
According to Bloomberg, ZimVie ZIMV is exploring a number of possibilities, including a whole firm sale. Shares of ZimVie rose 24%.
According to Bloomberg, Sanofi SAN requested preliminary offers for its $20 billion consumer health division. Shares of Sanofi rose 0.5%.
Novo Nordisk NOVO_B obtained regulatory approval in China for their cardiovascular risk reduction weight-loss medication. The stock increased by 3%.
